MYLAN 2035 MYLAN 2035 (Topiramate (sprinkle) 15 mg)
Pill imprint MYLAN 2035 MYLAN 2035 has been identified as Topiramate (sprinkle) 15 mg.
Topiramate is used in the treatment of obesity; bipolar disorder; migraine prevention; fibromyalgia; seizure prevention (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 2035 MYLAN 2035 (Topiramate (sprinkle) 15 mg)
More about topiramate
- Topiramate extended-release capsules
- Topiramate sprinkle capsules
- Topiramate (Advanced Reading)